213 related articles for article (PubMed ID: 30995899)
1. EP1 receptor is involved in prostaglandin E2-induced osteosarcoma growth.
Niu JC; Ma N; Liu W; Wang PJ
Bosn J Basic Med Sci; 2019 Aug; 19(3):265-273. PubMed ID: 30995899
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human glioma cell growth by a PHS-2 inhibitor, NS398, and a prostaglandin E receptor subtype EP1-selective antagonist, SC51089.
Matsuo M; Yoshida N; Zaitsu M; Ishii K; Hamasaki Y
J Neurooncol; 2004 Feb; 66(3):285-92. PubMed ID: 15015658
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 receptor 1 activity regulates cell survival following hypoxia in cultured rat cortical neurons.
Liu ML; Zhang YQ; Zhang YN; Pei LC; Liu X
Neurosci Lett; 2012 Feb; 508(1):31-6. PubMed ID: 22198374
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of the prostaglandin E2 EP1 receptor in MDCK cells increases growth through activation of Akt and the epidermal growth factor receptor.
Taub M; Parker R; Mathivanan P; Ariff MA; Rudra T
Am J Physiol Renal Physiol; 2014 Sep; 307(5):F539-50. PubMed ID: 25007872
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 upregulates β1 integrin expression via the E prostanoid 1 receptor/nuclear factor κ-light-chain-enhancer of activated B cells pathway in non-small-cell lung cancer cells.
Bai X; Yang Q; Shu W; Wang J; Zhang L; Ma J; Xia S; Zhang M; Cheng S; Wang Y; Leng J
Mol Med Rep; 2014 May; 9(5):1729-36. PubMed ID: 24584670
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection by PGE2 receptor EP1 inhibition involves the PTEN/AKT pathway.
Zhou P; Qian L; Chou T; Iadecola C
Neurobiol Dis; 2008 Mar; 29(3):543-51. PubMed ID: 18178094
[TBL] [Abstract][Full Text] [Related]
7. Toxic role of prostaglandin E2 receptor EP1 after intracerebral hemorrhage in mice.
Zhao X; Wu T; Chang CF; Wu H; Han X; Li Q; Gao Y; Li Q; Hou Z; Maruyama T; Zhang J; Wang J
Brain Behav Immun; 2015 May; 46():293-310. PubMed ID: 25697396
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 increases proximal tubule fluid reabsorption, and modulates cultured proximal tubule cell responses via EP1 and EP4 receptors.
Nasrallah R; Hassouneh R; Zimpelmann J; Karam AJ; Thibodeau JF; Burger D; Burns KD; Kennedy CR; Hébert RL
Lab Invest; 2015 Sep; 95(9):1044-55. PubMed ID: 26121313
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2 stimulates β1-integrin expression in hepatocellular carcinoma through the EP1 receptor/PKC/NF-κB pathway.
Bai X; Wang J; Guo Y; Pan J; Yang Q; Zhang M; Li H; Zhang L; Ma J; Shi F; Shu W; Wang Y; Leng J
Sci Rep; 2014 Oct; 4():6538. PubMed ID: 25289898
[TBL] [Abstract][Full Text] [Related]
10. Urodynamic effects of intravenous and intrathecal administration of E-series prostaglandin 1 receptor antagonist on detrusor overactivity in rats with spinal cord injury.
Wada N; Kadekawa K; Majima T; Shimizu T; Tyagi P; Kakizaki H; Yoshimura N
Neurourol Urodyn; 2018 Jan; 37(1):132-137. PubMed ID: 28608967
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E₂ receptor EP1-mediated phosphorylation of focal adhesion kinase enhances cell adhesion and migration in hepatocellular carcinoma cells.
Bai X; Wang J; Zhang L; Ma J; Zhang H; Xia S; Zhang M; Ma X; Guo Y; Rong R; Cheng S; Shu W; Wang Y; Leng J
Int J Oncol; 2013 May; 42(5):1833-41. PubMed ID: 23525457
[TBL] [Abstract][Full Text] [Related]
12. Effect of selective inhibition or activation of PGE2 EP1 receptor on glomerulosclerosis.
Chen X; Yin J; Xu Y; Qiu Z; Liu J; Chen X
Mol Med Rep; 2020 Oct; 22(4):2887-2895. PubMed ID: 32700746
[TBL] [Abstract][Full Text] [Related]
13. Intracerebral hemorrhage outcomes following selective blockade or stimulation of the PGE2 EP1 receptor.
Leclerc JL; Ahmad AS; Singh N; Soshnik-Schierling L; Greene E; Dang A; Doré S
BMC Neurosci; 2015 Aug; 16():48. PubMed ID: 26232001
[TBL] [Abstract][Full Text] [Related]
14. Astragalus polysaccharides decrease proliferation, migration, and invasion but increase apoptosis of human osteosarcoma cells by up-regulation of microRNA-133a.
Chu Y; Fang Y; Chi J; Li J; Zhang D; Zou Y; Wang Z
Braz J Med Biol Res; 2018 Nov; 51(12):e7665. PubMed ID: 30462772
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 type 1 receptors contribute to neuronal apoptosis after transient forebrain ischemia.
Shimamura M; Zhou P; Casolla B; Qian L; Capone C; Kurinami H; Iadecola C; Anrather J
J Cereb Blood Flow Metab; 2013 Aug; 33(8):1207-14. PubMed ID: 23632967
[TBL] [Abstract][Full Text] [Related]
16. PGE
Gonzalez AA; Salinas-Parra N; Leach D; Navar LG; Prieto MC
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F1038-F1049. PubMed ID: 28701311
[TBL] [Abstract][Full Text] [Related]
17. STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma.
Oi T; Asanuma K; Matsumine A; Matsubara T; Nakamura T; Iino T; Asanuma Y; Goto M; Okuno K; Kakimoto T; Yada Y; Sudo A
Int J Oncol; 2016 Dec; 49(6):2275-2284. PubMed ID: 27840900
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 EP1 receptor enhances TGF-β1-induced mesangial cell injury.
Chen X; Jiang D; Wang J; Chen X; Xu X; Xi P; Fan Y; Zhang X; Guan Y
Int J Mol Med; 2015 Jan; 35(1):285-93. PubMed ID: 25352206
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA‑22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma.
Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Sun L; Sun C; Feng W; Guo SB
Mol Med Rep; 2020 Nov; 22(5):3911-3921. PubMed ID: 33000186
[TBL] [Abstract][Full Text] [Related]
20. Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke.
Frankowski JC; DeMars KM; Ahmad AS; Hawkins KE; Yang C; Leclerc JL; Doré S; Candelario-Jalil E
Sci Rep; 2015 Dec; 5():17956. PubMed ID: 26648273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
